WO2011002892A2 - Process for separating and recovering 3-hydroxypropionic acid - Google Patents
Process for separating and recovering 3-hydroxypropionic acid Download PDFInfo
- Publication number
- WO2011002892A2 WO2011002892A2 PCT/US2010/040613 US2010040613W WO2011002892A2 WO 2011002892 A2 WO2011002892 A2 WO 2011002892A2 US 2010040613 W US2010040613 W US 2010040613W WO 2011002892 A2 WO2011002892 A2 WO 2011002892A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydroxypropionic acid
- salt
- acid
- electrodialysis
- liter
- Prior art date
Links
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 title claims abstract description 400
- 238000000034 method Methods 0.000 title claims abstract description 121
- 238000000909 electrodialysis Methods 0.000 claims abstract description 120
- 150000003839 salts Chemical class 0.000 claims abstract description 102
- 239000012528 membrane Substances 0.000 claims abstract description 87
- 239000002253 acid Substances 0.000 claims abstract description 53
- 239000007864 aqueous solution Substances 0.000 claims abstract description 48
- 239000012141 concentrate Substances 0.000 claims abstract description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 51
- 238000000855 fermentation Methods 0.000 claims description 36
- 230000004151 fermentation Effects 0.000 claims description 36
- 244000005700 microbiome Species 0.000 claims description 35
- 150000001768 cations Chemical class 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 9
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 37
- 239000000243 solution Substances 0.000 description 37
- AVXDKPABPXSLIZ-UHFFFAOYSA-M sodium;3-hydroxypropanoate Chemical compound [Na+].OCCC([O-])=O AVXDKPABPXSLIZ-UHFFFAOYSA-M 0.000 description 23
- 239000002585 base Substances 0.000 description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000012267 brine Substances 0.000 description 12
- 238000005341 cation exchange Methods 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 241000233866 Fungi Species 0.000 description 8
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- POODSGUMUCVRTR-IEXPHMLFSA-N acryloyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C=C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 POODSGUMUCVRTR-IEXPHMLFSA-N 0.000 description 6
- 239000003011 anion exchange membrane Substances 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 6
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 6
- 238000011020 pilot scale process Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000005349 anion exchange Methods 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000003014 ion exchange membrane Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- -1 pentose sugars Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 3
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000146399 Ceriporiopsis Species 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- 241000221779 Fusarium sambucinum Species 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000001311 chemical methods and process Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 229910052602 gypsum Inorganic materials 0.000 description 3
- 239000010440 gypsum Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000009285 membrane fouling Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241000123346 Chrysosporium Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 241000567163 Fusarium cerealis Species 0.000 description 2
- 241000146406 Fusarium heterosporum Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241000233654 Oomycetes Species 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- QLKFVDREXTWEGP-BLPRJPCASA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3r)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate;3-hydroxypropanoic acid Chemical compound OCCC(O)=O.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QLKFVDREXTWEGP-BLPRJPCASA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- VIWKEBOLLIEAIL-FBMOWMAESA-N lactoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VIWKEBOLLIEAIL-FBMOWMAESA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009105 vegetative growth Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- 108030005924 3-hydroxypropionyl-CoA dehydratases Proteins 0.000 description 1
- OAKURXIZZOAYBC-UHFFFAOYSA-M 3-oxopropanoate Chemical compound [O-]C(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-M 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228215 Aspergillus aculeatus Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000892910 Aspergillus foetidus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241001480052 Aspergillus japonicus Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193747 Bacillus firmus Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000222490 Bjerkandera Species 0.000 description 1
- 241000222478 Bjerkandera adusta Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241001466517 Ceriporiopsis aneirina Species 0.000 description 1
- 241001646018 Ceriporiopsis gilvescens Species 0.000 description 1
- 241001277875 Ceriporiopsis rivulosa Species 0.000 description 1
- 241000524302 Ceriporiopsis subrufa Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000985909 Chrysosporium keratinophilum Species 0.000 description 1
- 241001674013 Chrysosporium lucknowense Species 0.000 description 1
- 241001556045 Chrysosporium merdarium Species 0.000 description 1
- 241000080524 Chrysosporium queenslandicum Species 0.000 description 1
- 241001674001 Chrysosporium tropicum Species 0.000 description 1
- 241000355696 Chrysosporium zonatum Species 0.000 description 1
- 241000233652 Chytridiomycota Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- 235000001673 Coprinus macrorhizus Nutrition 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000145614 Fusarium bactridioides Species 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241001112697 Fusarium reticulatum Species 0.000 description 1
- 241001014439 Fusarium sarcochroum Species 0.000 description 1
- 241000223192 Fusarium sporotrichioides Species 0.000 description 1
- 241001465753 Fusarium torulosum Species 0.000 description 1
- 241000567178 Fusarium venenatum Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 241000146398 Gelatoporia subvermispora Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 241000411968 Ilyobacter Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000226677 Myceliophthora Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000233892 Neocallimastix Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 241001072230 Oceanobacillus Species 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000222385 Phanerochaete Species 0.000 description 1
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
- 241000222395 Phlebia Species 0.000 description 1
- 241000222397 Phlebia radiata Species 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 241000235379 Piromyces Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 235000001006 Saccharomyces cerevisiae var diastaticus Nutrition 0.000 description 1
- 244000206963 Saccharomyces cerevisiae var. diastaticus Species 0.000 description 1
- 241000204893 Saccharomyces douglasii Species 0.000 description 1
- 241001407717 Saccharomyces norbensis Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 241000958303 Streptomyces achromogenes Species 0.000 description 1
- 241001468227 Streptomyces avermitilis Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241000187392 Streptomyces griseus Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 241001540751 Talaromyces ruber Species 0.000 description 1
- 241000228178 Thermoascus Species 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 241001313536 Thermothelomyces thermophila Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 241001495429 Thielavia terrestris Species 0.000 description 1
- 241001149964 Tolypocladium Species 0.000 description 1
- 241000222354 Trametes Species 0.000 description 1
- 241000222357 Trametes hirsuta Species 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 241000217816 Trametes villosa Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241000378866 Trichoderma koningii Species 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- 241000409279 Xerochrysium dermatitidis Species 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 241000758405 Zoopagomycotina Species 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940005348 bacillus firmus Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003010 cation ion exchange membrane Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000012062 charged aerosol detection Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 108010067653 lactate dehydratase Proteins 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/422—Electrodialysis
- B01D61/423—Electrodialysis comprising multiple electrodialysis steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/44—Ion-selective electrodialysis
- B01D61/445—Ion-selective electrodialysis with bipolar membranes; Water splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/58—Multistep processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2317/00—Membrane module arrangements within a plant or an apparatus
- B01D2317/02—Elements in series
- B01D2317/022—Reject series
Definitions
- the present invention relates to processes for separating and recovering 3- hydroxypropionic acid in an aqueous solution comprising a salt of 3-hydroxypropionic acid .
- Various methods for separating and recovering 3-hydroxypropionic acid from an aqueous solution ⁇ e.g. , fermentation broth) include, for example, acidification with a mineral acid, such as sulfuric acid, to allow recovery of the 3- hydroxypropionic acid with calcium sulfate (gypsum) as a by-product (WO 2007/042494).
- a mineral acid such as sulfuric acid
- gypsum calcium sulfate
- 3-hydroxyproionate produced using the gypsum process a ton of waste salt as calcium sulfate is produced, which usually land-filled.
- the present invention provides processes for separating and recovering the free acid of 3-hydroxypropionic acid in an aqueous solution comprising a salt of 3- hydroxypropionic acid.
- the present invention relates to processes for separating and recovering 3- hydroxypropionic acid, comprising :
- the present invention also relates to processes for separating and recovering a salt of 3-hydroxypropionic acid, comprising : subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to concentrating electrodialysis to concentrate the salt of 3-hydroxypropionic acid in the aqueous solution.
- the present invention also relates to processes for separating and recovering 3- hydroxypropionic acid, comprising : subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to bipolar membrane electrodialysis to convert the salt of 3- hydroxypropionic acid into the free acid of 3-hydroxypropionic acid.
- Figure 1 shows the conductivity within the diluate tank during concentrating electrodialysis.
- Figure 2 shows the conductivity within the brine tank during concentrating electrodialysis.
- Figure 3 shows the conductance of various known concentrations of sodium 3- hydroxypropionate solutions.
- Figure 4 shows the drop in pH within the acid tank during conversion of a solution of sodium 3-hydroxypropionate (25% w/w, 4.4 kg, 60.7 mS/cm, pH 6.87) in water to the free acid of 3-hydroxypropionic acid by bipolar membrane electrodialysis using a EUR2B pilot scale electrodialysis unit equipped with a EUR2B-7Bip stack, a solution of sodium 3-hydroxypropionate charged to the acid tank, a solution of sodium hydroxide (4 kg, 0.1 M) charged to the electrode rinse tank, and a solution of sodium hydroxide (4 kg, 0.5 M) charged to the base tank.
- Figure 5 shows the drop in conductivity within the acid tank during conversion of an aqueous solution of sodium 3-hydroxypropionate (25% w/w, 4.4 kg, 60.7 mS/cm, pH 6.87) in water to the free acid of 3-hydroxypropionic acid by bipolar membrane electrodialysis using a EUR2B pilot scale electrodialysis unit equipped with a EUR2B-7Bip stack, a solution of sodium 3-hydroxypropionate charged to the acid tank, a solution of sodium hydroxide (4 kg, 0.1 M) charged to the electrode rinse tank, and a solution of sodium hydroxide (4 kg, 0.5 M) charged to the base tank.
- Figure 6 shows the increase in conductivity within the base tank during conversion of a solution of sodium 3-hydroxypropionate (25% w/w, 4.4 kg, 60.7 mS/cm, pH 6.87) in water to the free acid of 3-hydroxypropionic acid by bipolar membrane electrodialysis using a EUR2B pilot scale electrodialysis unit equipped with a EUR2B-7Bip stack, a solution of sodium 3-hydroxypropionate charged to the acid tank, a solution of sodium hydroxide (4 kg, 0.1 M) charged to the electrode rinse tank, and a solution of sodium hydroxide (4 kg, 0.5 M) charged to the base tank.
- the present invention relates to processes for separating and recovering 3- hydroxypropionic acid, comprising : (a) subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to concentrating electrodialysis to concentrate the salt of 3- hydroxypropionic acid in the aqueous solution; and (b) subjecting the resulting concentrate to bipolar membrane electrodialysis to convert the salt of 3- hydroxypropionic acid into the free acid of 3-hydroxypropionic acid.
- a process of the present invention is high yielding, allows for separation of neutral components ⁇ e.g., glucose) from the salt of 3-hydroxypropionic acid, has no waste effluent like the current gypsum process, and allows for the sodium hydroxide produced in the process to be recycled back to a fermentation for pH control. Additionally, the process avoids the excess calcium sulfate byproduct mentioned above and can remove substantial amounts of color that sometimes occurs during fermentation, making the process a convenient method for simultaneous decolorizing treatment.
- neutral components ⁇ e.g., glucose
- the present invention also relates to processes for separating and recovering a salt of 3-hydroxypropionic acid, comprising : subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to concentrating electrodialysis to concentrate the salt of 3-hydroxypropionic acid in the aqueous solution.
- the present invention also relates to processes for separating and recovering 3- hydroxypropionic acid, comprising : subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to bipolar membrane electrodialysis to convert the salt of 3- hydroxypropionic acid into the free acid of 3-hydroxypropionic acid.
- references to "about” a value or parameter herein includes aspects that are directed to that value or parameter per se. For example, description referring to "about X” includes the aspect "X”.
- the salt of 3-hydroxypropionic acid can be any salt suitable for the processes of the present invention.
- a salt of 3-hydroxypropionic acid consists of the conjugate base of 3-hydroxypropionic acid and a cation.
- the cation can be, e.g. , any monovalent or divalent cation that can be used as the counter ion to 3-hydroxypropionate during electrodialysis.
- a monovalent cation may be preferred because it may possess better ion mobility across an ion exchange membrane during electrodialysis.
- a divalent cation can be used but may be more prone to membrane fouling.
- the cation of the salt of 3-hydroxypropionic acid is an alkali metal ⁇ e.g. , lithium, sodium, potassium).
- the cation of the salt of 3-hydroxypropionic acid is sodium. In another aspect, the cation of the salt of 3-hydroxypropionic acid is potassium. In another aspect, the cation of the salt of 3-hydroxypropionic acid is lithium. In another aspect, the cation of the salt of 3-hydroxypropionic acid is an alkali earth metal ⁇ e.g., magnesium, calcium). In one aspect, the cation of the salt of 3-hydroxypropionic acid is magnesium. In another aspect, the cation of the salt of 3-hydroxypropionic acid is calcium. In another aspect, the cation of the salt of 3-hydroxypropionic acid is an organic cation.
- the cation of the salt of 3-hydroxypropionic acid is polyatomic ⁇ e.g., ammonium).
- the salt of 3-hydroxypropionic is part of an aqueous composition comprising any two or more 3-hydroxypropionic salts ⁇ e.g. , any two or more 3- hydroxypropionic salts mentioned herein, such as sodium and potassium).
- the pH of a fermentation is controlled with one base yielding only one salt of 3- hydroxypropionic acid.
- the base can be, for example, sodium hydroxide, potassium hydroxide, or ammonium hydroxide.
- the aqueous solution comprising the salt of 3-hydroxypropionic acid can be any aqueous solution.
- the aqueous solution is a whole fermentation broth.
- the aqueous solution is a cell-free fermentation broth.
- the cell-free fermentation broth is a filtered solution with the majority of cellular debris and particulate matter removed ⁇ e.g. , greater than 50%, greater than 75%, greater than 85%, greater than 90%, greater than 95%, or greater than 98% of the cellular debris and particulate matter removed).
- microorganism may be any microorganism, e.g. , a prokaryote or a eukaryote, and/or any cell ⁇ e.g., any yeast cell) capable of the recombinant production of 3-hydroxypropionic acid as described below.
- the microorganism may be any gram-positive or gram-negative bacterium.
- Gram-positive bacteria include, but not limited to, Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus, and Streptomyces.
- Gram-negative bacteria include, but not limited to, Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Neisseria, Pseudomonas, Salmonella, and Ureaplasma.
- the microorganism may be any Bacillus cell including, but not limited to, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, and Bacillus thuringiensis cells.
- the bacterial microorganism may also be any Streptococcus cell including, but not limited to, Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, and Streptococcus equi subsp. Zooepidemicus cells.
- the bacterial microorganism may also be any Streptomyces cell including, but not limited to, Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, and Streptomyces lividans cells.
- the microorganism may also be a eukaryote, such as a mammalian, insect, plant, or fungal cell.
- the microorganism is a fungal cell.
- "Fungi” as used herein includes the phyla Ascomycota, Basidiomycota, Chytridiomycota, and Zygomycota (as defined by Hawksworth et al., In, Ainsworth and Bisby's Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge, UK) as well as the Oomycota (as cited in Hawksworth et al., 1995, supra, page 171) and all mitosporic fungi (Hawksworth et al., 1995, supra).
- the microorganism is a yeast cell.
- yeast as used herein includes ascosporogenous yeast (Endomycetales), basidiosporogenous yeast, and yeast belonging to the Fungi Imperfecti (Blastomycetes). Since the classification of yeast may change in the future, for the purposes of this invention, yeast shall be defined as described in Biology and Activities of Yeast (Skinner, F. A., Passmore, S. M., and Davenport, R. R., eds, Soc. App. Bacteriol. Symposium Series No. 9, 1980).
- the microorganism may be a Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia cell such as a Kluyveromyces lactis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, Saccharomyces oviformis, or Yarrowia lipolytica cell.
- the microorganism may be a filamentous fungal cell.
- “Filamentous fungi” include all filamentous forms of the subdivision Eumycota and Oomycota (as defined by Hawksworth et al., 1995, supra).
- the filamentous fungi are generally characterized by a mycelial wall composed of chitin, cellulose, glucan, chitosan, mannan, and other complex polysaccharides. Vegetative growth is by hyphal elongation and carbon catabolism is obligately aerobic. In contrast, vegetative growth by yeasts such as Saccharomyces cerevisiae is by budding of a unicellular thallus and carbon catabolism may be fermentative.
- the filamentous fungi may be an Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phlebia, Piromyces, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trametes, or Trichoderma cell.
- the filamentous fungi may be an Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Bjerkandera adusta, Ceriporiopsis aneirina, Ceriporiopsis caregiea, Ceriporiopsis gilvescens, Ceriporiopsis pannocinta, Ceriporiopsis rivulosa, Ceriporiopsis subrufa, Ceriporiopsis subvermispora, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium , Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium
- the microorganism is a bacterial or yeast strain that produces 3- hydroxypropionic acid.
- the bacterial strain is an E. coli strain that produces 3-hydroxypropionic acid .
- the microorganism is a metabolically engineered microorganism.
- the microorganism is a metabolically engineered E. coli strain.
- the microorganism is a metabolically engineered yeast strain.
- 3-hydroxypropionic acid is produced by culturing the microorganism in a culture medium such that 3-hydroxypropionic acid is produced.
- the culture media and/or culture conditions can be such that the microorganism grows to an adequate density and produces 3-hydroxypropionic acid efficiently.
- any method can be used such as those described elsewhere (Manual of Industrial Microbiology and Biotechnology, 2 nd Edition, Editors: A. L. Demain and J. E. Davies, ASM Press; and Principles of Fermentation Technology, P. F. Stanbury and A. Whitaker, Pergamon). Briefly, a large tank (e.g. , a 400 liters, 800 liters, 2000 liters, or more fermentation tank) containing appropriate culture medium with, for example, glucose as a carbon source is inoculated with a particular microorganism. After inoculation, the microorganism is incubated to allow biomass to be produced.
- a large tank e.g. , a 400 liters, 800 liters, 2000 liters, or more fermentation tank
- appropriate culture medium with, for example, glucose as a carbon source
- the microorganism is incubated to allow biomass to be produced.
- the broth containing the microorganism can be transferred to a second tank.
- This second tank can be any size.
- the second tank can be larger, smaller, or the same size as the first tank.
- the second tank is larger than the first such that additional culture medium can be added to the broth from the first tank.
- the culture medium within this second tank can be the same as, or different from, that used in the first tank.
- the first tank can contain medium with xylose, while the second tank contains medium with glucose.
- Production of the 3-hydroxypropionic acid can be performed by batch fermentation, fed-batch fermentation, or continuous fermentation. In certain aspects, it is desirable to perform the fermentation under reduced oxygen or anaerobic conditions for certain microorganisms. In other aspects, 3-hydroxypropionic acid production can be performed with oxygen; and, optionally with the use of an air-lift or equivalent fermentor.
- Fermentation parameters are dependent on the microorganism used for production of the 3-hydroxypropionic acid. Cultivation of the microorganism is preferably performed under aerobic or anaerobic conditions for about 0.5 to about 240 hours. During cultivation, temperature is preferably controlled at about 25°C to about 45°C, and pH is preferably controlled at about 5 to about 8. The pH can be adjusted using common acids or bases such as acetic acid or sodium hydroxide. In a preferred aspect, the pH of the fermentation is adjusted using one base so that the 3- hydroxypropionic acid is in the form of only one salt of 3-hydroxypropionic acid. The pH of the fermentation should be sufficiently high enough to allow growth of the microorganism and 3-hydroxypropionic acid production by the microorganism.
- Fermentable carbon sources can include hexose and pentose sugars ⁇ e.g., ribose, arabinose, xylose, and lyxose), starch, cellulose, xylan, oligosaccharides, and combinations thereof.
- examples of carbohydrates that cells are capable of metabolizing to pyruvate include sugars such as dextrose, triglycerides, and fatty acids.
- LB modified Luria-Bertani
- cultures of a microorganism e.g., an E. coli strain
- NBS mineral salts medium can be grown in NBS mineral salts medium (Causey et al., 2004, Proc. Natl. Acad. Sci. USA 101 : 2235-2240) and supplemented with 2% to 20% sugar (w/v) or either 5% or 10% sugar (glucose or sucrose).
- 4-Morpholinopropanesulfonic acid (0.1 M, pH 7.1) can be added to both liquid and solid media (filter-sterilized) when needed for pH control (and is optionally included in medium used for 10-liter fermentations).
- Minimal medium can also be prepared by using succinate (1 g/liter) as a sole source of carbon (nonfermentable substrate) and can be added as a supplement to glucose-minimal medium when needed.
- antibiotics can be included as needed.
- the 3-hydroxypropionic acid is produced via pyruvate through lactate by engineering the metabolic steps leading from pyruvate to 3-hydroxypropionic acid to allow for unimpeded flow of intermediates from pyruvate to 3-hydroxypropionic acid.
- the 3-hydroxypropionic acid is produced via pyruvate through acetyl-CoA by engineering the metabolic steps leading from pyruvate to 3- hydroxypropionic acid to allow for unimpeded flow of intermediates from pyruvate to 3- hydroxypropionic acid.
- the 3-hydroxypropionic acid is produced from propionate through propionyl-CoA and acrylyl-CoA by engineering the metabolic steps leading from pyruvate to 3-hydroxypropionic acid to allow for unimpeded flow of intermediates from propionate to 3-hydroxypropionic acid.
- the 3-hydroxypropionic acid is produced via phosphoenolpyruvate or pyruvate through beta-alanine and acrylyl-CoA by engineering the metabolic steps leading from phosphoenolpyruvate or pyruvate to 3- hydroxypropionic acid to allow for unimpeded flow of intermediates from phosphoenolpyruvate or pyruvate to 3-hydroxypropionic acid.
- the 3-hydroxypropionic acid is produced via phosphoenolpyruvate or pyruvate through beta-alanine and malonate semialdehyde by engineering the metabolic steps leading from phosphoenolpyruvate or pyruvate to 3- hydroxypropionic acid to allow for unimpeded flow of intermediates from phosphoenolpyruvate or pyruvate to 3-hydroxypropionic acid.
- the 3-hydroxypropionic acid is produced wherein lactate is contacted with a CoA transferase or a CoA synthetase such that lactyl-CoA is formed, then contacting the lactyl-CoA with a lactyl-CoA dehydratase to form acrylyl-CoA, then contacting the acrylyl-CoA with a 3-hydroxypropionyl-CoA dehydratase to form
- 3-hydroxypropionic acid-CoA 3-hydroxypropionic acid-CoA, and then contacting the 3-hydroxypropionic acid-CoA with the CoA transferase or the CoA synthetase to form 3-hydroxypropionic acid or with a
- the 3-hydroxypropionic acid is preferably produced by a microorganism, e.g., yeast or E. coli, at a concentration of preferably at least about 20 g, more preferably at least about 40 g, more preferably at least about 60 g, more preferably at least about 80 g, even more preferably at least about 100 g, most preferably at least about 120 g, and even most preferably at least about 140 g per liter.
- a microorganism e.g., yeast or E. coli
- the aqueous solution comprising a salt of 3-hydroxypropionic acid may also be obtained from methods other than fermentation, such as chemical processes. See, for example, WO 2005/003074, which discloses production of the free acid of 3- hydroxypropionic from the hydration of acrylic acid; where the salt is easily produced from the hydration of acrylic acid followed by the addition of a base.
- any method known in the art can be used. See, for example, Applied Environmental Microbiology 59: 4261-4265 (1993) and Sullivan and Clarke, 1955, J. Assoc. Offic. Agr. Chemists, 38: 514-518.
- the 3-hydroxypropionic acid is produced, common separation techniques can be used to remove the biomass from the broth, such as flitration or centrifugation. If the 3-hydroxypropionic acid is secreted into the nutrient medium, the 3- hydroxypropionic acid can be recovered directly from the medium. If the 3- hydroxypropionic acid is not secreted into the medium, the 3-hydroxypropionic acid can be recovered from cell lysates.
- Electrodialysis is defined herein as a process used to transport ions from one solution through ion-exchange membranes to another solution under the influence of an applied electric potential difference.
- electrodialysis can separate, concentrate, and/or purify a charged component of interest, e.g., 3-hydroxypropionate, from aqueous solutions, such as fermentation broth.
- an aqueous solution comprising a salt of 3-hydroxypropionic acid is subjected to concentrating electrodialysis to concentrate the salt of 3-hydroxypropionic acid in the aqueous solution.
- the aqueous solution comprising a salt of 3-hydroxypropionic acid is subjected to bipolar membrane electrodialysis to convert the salt of 3-hydroxypropionic acid into the free acid of 3-hydroxypropionic acid.
- the aqueous solution comprising a salt of 3-hydroxypropionic acid is subjected to concentrating electrodialysis to concentrate the salt of 3-hydroxypropionic acid followed by bipolar membrane electrodialysis to convert the salt of 3-hydroxypropionic acid into the free acid of 3- hydroxypropionic acid.
- sodium hydroxide produced during the processes of the present invention is recycled to a fermentation for pH control. The recycling may be conducted using methods known in the art.
- the pH of the aqueous solution comprising the salt of 3- hydroxypropionic acid is preferably at least 6, more preferably at least 6.5, even more preferably at least 7, most preferably at least 7.5, and even most preferably at least 8.
- the pH can be adjusted using common acids or bases such as acetic acid or sodium hydroxide.
- the pH of the aqueous solution is adjusted using one base yielding only one salt of 3-hydroxypropionic acid.
- a base can be, for example, sodium hydroxide, potassium hydroxide, or ammonium hydroxide.
- the aqueous solution Prior to electrodialysis, the aqueous solution can be further submitted to other pretreatments such as ion exchange to remove trace amounts of mutlivalent cations such as calcium, iron, or magnesium to prevent membrane fouling and/or to decolorization using agents such as decolorizing carbon.
- pretreatments such as ion exchange to remove trace amounts of mutlivalent cations such as calcium, iron, or magnesium to prevent membrane fouling and/or to decolorization using agents such as decolorizing carbon.
- the first step may involve concentrating electrodialysis, which is based on the property of ion-exchange membranes.
- the membranes used in concentrating electrodialysis are selectively charged in order to separate ions (i.e., cations and anions). If the membrane is positively charged, only anions will be allowed through. Such a membrane is called an anion-exchange membrane. Similarly, a negatively charged membrane is called a cation-exchange membrane. This membrane property is known as permselectivity.
- Any anion-exchange membrane or cation-exchange membrane suitable for concentrating electrodialysis can be used in the processes of the present invention. Such membranes are commercially available from Astom Corp.
- Neosepta membranes e.g., Neosepta membranes, Tokuyama Co., Ltd. (Tokyo, Japan), Ameridia (Somerset, NJ, USA), Eurodia Industrie S. A. (Wissous, France), CelTech, Inc. (Fayetteville, NC, USA), Eden Purification Systems (North Haven, CT, USA), Ion Power, Inc. (Bear, DE, USA), Minntech Corporation (Minneapolis, MN, USA), and GE Water & Process Technologies (Trevose, PA, USA).
- the concentrating electrodialysis can be performed with any available concentrating electrodialysis unit.
- Such units are available commercially from suppliers such as Eet Corporation (Harriman, Tennessee, USA), Mega A. S. (Drahobejlova, Praha, Czech Republic), or Ameridia (Somerset, New Jersey, USA), a division of Eurodia Insdustrie S. A. (Wissous, France).
- Eet Corporation Harriman, Tennessee, USA
- Mega A. S. Drahobejlova, Praha, Czech Republic
- Ameridia Somerset, New Jersey, USA
- a division of Eurodia Insdustrie S. A. (Wissous, France).
- a concentrating electrodialysis unit from Ameridia is described below.
- the concentrating electrodialysis is preferably performed using a configuration known as an electrodialysis cell.
- the cell consists of a feed (diluate) compartment and a concentrate (brine) compartment formed by an anion exchange membrane and a cation exchange membrane placed between two electrodes.
- the electrodialysis process preferably employs multiple electrodialysis cells arranged into a configuration known as an electrodialysis stack, with alternating anion and cation exchange membranes forming the multiple electrodialysis cells.
- the number of cells can range from a few, e.g., ten cells, to hundreds of cells in one stack.
- a clamping system keeps the assembly together under a uniform closing pressure.
- the driving force is a direct current between anodes (positive electrodes) and cathodes (negative electrodes) housed at the two ends of the stack.
- the parameters include current density, cell voltage, current efficiency, diluate concentration, and concentrate concentration.
- the current density is the driving force of the process as it determines the quantity of equivalent grams of product that are transported across the membranes. Running at a high current density reduces the required surface of electrodialysis cells. However, the current density has to be balanced with a disproportionate cell voltage increase resulting in higher power consumption.
- the term "limiting current” is defined herein as the maximum allowed current density to avoid a steep cell voltage increase. The limiting current is known in the art to depend on parameters such as stack design, solution concentrations, temperature, etc.
- Current efficiency also determines the surface of membranes required for the processes of the present invention.
- the term "current efficiency” is defined herein as the efficiency of an electrochemical process. The amount of material obtained during electrolysis is generally less than that expected due to loss of energy during its flow through the system and due to other side-reactions taking place during electrolysis. The current efficiency takes into consideration all the parasitic phenomena occurring in the stack, such as the non-perfect permselectivity of membranes or physical leakage (leading to impurities in the products), that can be reduced by optimized stack design and membrane selection.
- concentrations are important parameters.
- concentrations conductivities
- the ratio of conductivities affects the current efficiency, limiting the maximum concentration for the concentrate (brine) stream.
- the minimum diluate concentration is limited by conductivity considerations due to the ohmic resistance of the diluate cells and the low limiting currents at low conductivities.
- the minimum conductivity that can be considered is approximately 0.5 mS/cm.
- the minimum starting concentration of the salt of 3-hydroxypropionic acid for performing concentrating electrodialysis is one whose conductivity is preferably at least 10 mS/cm (20 g/liter), more preferably at least 20 mS/cm (40 g/liter), even more preferably at least 40 mS/cm (80 g/liter), and most preferably at least 60 mS/cm (120 g/liter).
- Membrane fouling and stack plugging can result from impurities in the aqueous solution, either soluble or insoluble, such as organic matter, colloidal substances, microorganisms (e.g., yeast or bacteria), insoluble salts, etc.
- the aqueous solution is preferably pretreated to remove impurities and particulate matter. Any pretreatment method known in the art can be used. For example, typical methods include, but are not limited to, centrifugation, microfiltration, nanofiltration, and ion exchange. However, when membranes become fouled with such impurities, they can be cleaned using standard methods known in the art such as the use of current reversal or dilute acid, caustic, and/or enzyme solutions.
- the maximum temperature range in concentrating electrodialysis stacks is typically about 10°C to about 40°C.
- the maximum pH range in concentrating electrodialysis stacks is typically about 4 to about 8.
- the optimal pH range is dependent not only on the type of membrane used, but also on the pKa of 3- hydroxypropionic acid.
- the concentrating electrodialysis may be conducted at a temperature in the range of about 10°C to about 40°C, or about 15°C to about 35°C, or about 20°C to about 30°C.
- the concentrating electrodialysis may be conducted at a pH that is at least about 6, at least about 6.5, at least about 7, at least about 7.5, or at least about 8.
- the aqueous solution comprising the salt of 3-hydroxypropionic acid is fed into the electrodialysis stack through the diluate compartment.
- the direct current (DC) voltage causes the positively charged cations to migrate toward the cathode and the negatively charged anions to migrate toward the anode.
- the membrane properties determine whether the ions are rejected or allowed to pass through.
- the ions that can pass through the membranes are retained in the next compartment since the next membrane in its path will be of the opposite charge. Therefore, there are compartments from where the ions are removed and some compartments where they are concentrated. If the solutions are circulated rapidly through the stack, a diluate and a concentrate stream are obtained.
- the product can be the desalted stream, the concentrate stream, or both.
- the low amount of water transported with the salt across the membranes (known as "concentration transport") enables the brine stream to have a higher concentration than the feed stream. Therefore, it is possible not only to remove salts from a solution, but also to concentrate a solution by electrodialysis.
- the present invention utilizes this concentrating electrodialysis to concentrate the aqueous solution of the salt of 3- hydroxypropionic acid.
- the maximum concentration of the salt of 3-hydroxypropionic acid obtained by concentrating electrodialysis is about 100 g/liter, about 125 g/liter, about 150 g/liter, about 175 g/liter, about 200 g/liter, about 250 g/liter, or about 300 g/liter.
- the second step may involve contacting the resulting concentrate from the concentrating electrodialysis to bipolar membrane electrodialysis to convert the salt of 3-hydroxypropionic acid into the free acid of 3- hydroxypropionic acid.
- the concentrating step may be omitted (e.g., in cases where the concentration of 3-hydroxypropionic acid is sufficiently high).
- the bipolar membrane electrodialysis can be performed with any available bipolar membrane electrodialysis unit.
- Such units are available commercially from suppliers such as The Electrosynthesis Company, Inc. (Lancaster, NY, USA), FuMA-Tech GmbH (Vaihingen, Germany), Solvay SA (Brussels, Belgium), Tokuyama Co., Ltd. (Tokyo, Japan), Graver Water Co. (USA), Tianwei, Membrane Technology Co. Ltd. (Shandong, China), Ameridia (Somerset, New Jersey, USA), a division of Eurodia Insdustrie S. A. (Wissous, France).
- a bipolar membrane electrodialysis unit from Ameridia is described below.
- bipolar membrane electrodialysis is also preferably performed using an electrodialysis cell.
- Bipolar membrane electrodialysis is defined herein as a process that allows efficient conversion of aqueous salt solutions into acids and bases without chemical addition.
- bipolar membrane electrodialysis is an electrodialysis process where bipolar membranes carry out the dissociation of water, also called water splitting, in the presence of an electric field.
- this process allows one to directly acidify or basify process streams without adding chemicals, avoiding by-product or waste streams and costly downstream purification steps.
- a bipolar membrane Under the driving force of an electrical field, a bipolar membrane dissociates water into hydrogen (H+) and hydroxyl (OH-) ions.
- a bipolar membrane is formed of an anion- and a cation-exchange layer that are bound together, and a very thin interface where the water diffuses from the outside aqueous salt solutions. With the anion- exchange side facing the anode and the cation-exchange side facing the cathode, the hydroxyl anions will be transported across the anion-exchange layer and the hydrogen cations across the cation-exchange layer.
- a bipolar membrane allows the generation and concentration of hydroxyl and hydrogen ions at its surface.
- ions can be used in an electrodia lysis stack to combine with the cations and anions of the salt to produce acids and bases.
- bipolar membrane electrodialysis is used to convert a solution of the salt of 3-hydroxypropionic acid to the free acid of 3- hydroxypropionic acid.
- Any bipolar membrane suitable for bipolar membrane electrodialysis can be used in the processes of the present invention.
- Such membranes are commercially available from Astom Corp. (Tokyo, Japan), e.g., Neosepta membranes, Tokuyama Co., Ltd. (Tokyo, Japan), Ameridia (Somerset, NJ, USA), Eurodia Industrie S. A. (Wissous, France), CelTech, Inc. (Fayetteville, NC, USA), Eden Purification Systems (North Haven, CT, USA), Ion Power, Inc. (Bear, DE, USA), Minntech Corporation (Minneapolis, MN, USA), and GE Water & Process Technologies (Trevose, PA, USA)
- the minimum starting concentration of the salt of 3-hydroxypropionic acid for performing bipolar membrane electrodialysis is one whose conductivity is preferably at least 10 mS/cm or 20 g/liter.
- the bipolar membrane electrodialysis is conducted at a temperature in the range of about 10°C to about 40°C, about 15°C to about 35°C, or about 20°C to about 30°C.
- the bipolar membrane electrodialysis may be conducted at a pH that is at least about 6, at least about 6.5, at least about 7, at least 7.5 about, or at least about 8.
- the maximum concentration of the free acid of 3-hydroxypropionic acid obtained by bipolar membrane electrodialysis is preferably about 300 g/liter.
- the conversion of the salt of 3- hydroxypropionic acid to the free acid of 3-hydroxypropionic acid is at least 90%, at least 92%, at least 95%, or at least 98%.
- the concentrating electrodialysis unit and the bipolar membrane electrodialysis unit can be integrated into the same apparatus.
- Different bipolar membrane electrodialysis configurations are possible and described by manufacturers.
- a three-compartment cell is obtained by adding the bipolar membrane in a concentrating electrodialysis cell.
- the bipolar membrane is flanked on either side by the anion- and cation-exchange membranes described above to form three compartments: acid between the bipolar and the anion-exchange membranes, base between the bipolar and the cation- exchange membranes, and salt between the cation- and anion-exchange membranes.
- a two-compartment cell can be obtained by adding bipolar and cation-exchange membranes or by adding bipolar and anion- exchange membranes.
- a two compartment cell with alternating cation-exchange membranes and bipolar membranes is utilized.
- the processes may further comprise recovering the salt of 3-hydroxypropionic acid or the free acid of 3-hydroxypropionic acid using any method known in the art.
- Such non- limiting methods may include precipitation e.g., calcium sulfate, crystallization, and extraction.
- the 3-hydroxypropionic acid obtained according to the processes of the present invention can be used, e.g., to obtain other organic compounds such as 1,3-propanediol, acrylic acid, polymerized acrylate, esters of acrylate, esters of 3-hydroxypropionic acid, and polymerized 3-hydroxypropionic acid.
- 3-hydroxypropionic acid can be modified into a derivative such as polymerized 3-hydroxypropionic acid or an ester of 3- hydroxypropionic acid.
- a chemical process can be used to produce a particular compound that is converted into another organic compound (e.g., 1,3-propanediol, acrylic acid, polymerized acrylate, esters of acrylate, esters of 3-hydroxypropionic acid, and polymerized 3-hydroxypropionic acid) using a cell, substantially pure polypeptide, and/or cell-free extract.
- a chemical process can be used to produce acrylyl-CoA, while a microorganism can be used convert acrylyl-CoA into 3- hydroxypropionic acid (see U.S. Patent No. 7,186,541 and "Top Value Added Chemicals from Biomass", Pacific Northwest National Laboratory and National Renewable Energy Laboratory, T. Werpy and G. Petersen, August 2004).
- the unit was supplied with two electrodialysis stacks, one for concentrating electrodialysis (EUR2B-10 stack) and the other (EUR2B-7Bip) for bipolar membrane electrodialysis.
- the EUR2B-10 stack consists of 10 cells with alternating anion- and cation- exchange membranes (NEOSEPTA® ion exchange membranes (Astom Corp., Tokyo, Japan). The area of each membrane was 2dm 2 . The EUR2B-10 stack was used for concentrating a sodium 3-hydroxypropionate solution.
- the EUR2B-7Bip stack consists of 7 cells with alternating cationic and bipolar membranes (NEOSEPTA® BP-IE membranes (Astom Corp., Tokyo, Japan). The area of each membrane was 2dm 2 .
- the EUR2B-7Bip stack was used for converting a solution of sodium 3-hydroxypropionate to its free acid.
- Example 1 Concentration of a sodium 3-hydroxypropionate solution using concentrating electrodialysis
- a solution of sodium 3-hydroxypropionate (10% w/w, 8.0 kg) in water was concentrated by concentrating electrodialysis using a EUR2B pilot scale electrodialysis unit equipped with a EUR2B-10 stack as described above.
- the solution of sodium 3- hydroxypropionate with a conductance of 43 mS/cm and a pH of 6.7 was charged to the diluate tank.
- a solution of potassium nitrate (20 mS/cm, 4.0 kg) was charged to the electrode rinse tank.
- a dilute solution of sodium 3-hydroxypropionate (10 mS/cm) was charged to the brine tank.
- the final conductance within the diluate tank was 6.4 mS/cm, which corresponded to a final diluate concentration of ⁇ 1% (w/w) or a 93% yield in transfer of sodium 3-hydroxypropionate for this batch process.
- Example 2 Separation of a mixture of sodium 3-hydroxypropionate and glucose by concentrating electrodialysis
- a mixture of sodium 3-hydroxypropionate and glucose was separated by concentrating electrodialysis using the same procedure described in Example 1.
- Glucose was added at a concentration of 0.5% (w/w) to a sodium 3-hydroxypropionate solution (10% w/w, 8.0 kg) in water in the initial diluate tank.
- samples from the brine tank and the diluate tank were evaluated by HPLC as described in Example 1.
- the diluate tank showed that the glucose remained behind and did not migrate to the brine tank.
- the brine tank was completely free of glucose and showed only components of the original sodium 3-hydroxypropionate sample.
- Example 3 Conversion of a solution of sodium 3-hydroxypropionate to the free acid of 3-hydroxypropionic acid by bipolar membrane electrodialysis
- a solution of sodium 3-hydroxypropionate (25% w/w, 4.4 kg, 60.7 mS/cm, pH 6.87) in water was converted to the free acid of 3-hydroxypropionic acid by bipolar membrane electrodialysis using a EUR2B pilot scale electrodialysis unit equipped with a EUR2B-7Bip stack as described above.
- the solution of sodium 3-hydroxypropionate was charged to the acid tank.
- a solution of sodium hydroxide (4 kg, 0.1 M) was charged to the electrode rinse tank.
- a solution of sodium hydroxide (4 kg, 0.5 M) was charged to the base tank.
- the solutions were circulated through the EUR2B-7Bip stack at a flow rate of about 0.8 gpm using a DC power supply at initial settings of 20 amps and 19 volts.
- a process for separating and recovering 3-hydroxypropionic acid comprising : (a) subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to concentrating electrodialysis to concentrate the salt of 3-hydroxypropionic acid in the aqueous solution; and
- 150 g/liter more preferably about 175 g/liter, more preferably about 200 g/liter, even more preferably about 250 g/liter, and most preferably about 300 g/liter.
- 3-hydroxypropionic acid to the free acid of 3-hydroxypropionic acid is preferably at least 90%, more preferably at least 92%, even more preferably at least 95%, and most preferably at least 98%.
- a process for separating and recovering a salt of 3-hydroxypropionic acid comprising : subjecting an aqueous solution comprising the salt of 3-hydroxypropionic acid to concentrating electrodialysis to concentrate the salt of 3-hydroxypropionic acid in the aqueous solution.
- a process for separating and recovering 3-hydroxypropionic acid comprising : subjecting an aqueous solution comprising a salt of 3-hydroxypropionic acid to bipolar membrane electrodialysis to convert the salt of 3-hydroxypropionic acid into the free acid of 3-hydroxypropionic acid.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1014011A BRPI1014011A2 (en) | 2009-07-01 | 2010-06-30 | process for separating and recovering 3-hydroxypropionic acid. |
CN2010800387921A CN102482692A (en) | 2009-07-01 | 2010-06-30 | Process for separating and recovering 3-hydroxypropionic acid |
US13/379,572 US20120160686A1 (en) | 2009-07-01 | 2010-06-30 | Process for separating and recovering 3-hydroxypropionic acid |
EP10729773A EP2449122A2 (en) | 2009-07-01 | 2010-06-30 | Process for separating and recovering 3-hydroxypropionic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22230209P | 2009-07-01 | 2009-07-01 | |
US61/222,302 | 2009-07-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011002892A2 true WO2011002892A2 (en) | 2011-01-06 |
WO2011002892A3 WO2011002892A3 (en) | 2011-04-14 |
Family
ID=43067203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/040613 WO2011002892A2 (en) | 2009-07-01 | 2010-06-30 | Process for separating and recovering 3-hydroxypropionic acid |
Country Status (5)
Country | Link |
---|---|
US (1) | US20120160686A1 (en) |
EP (1) | EP2449122A2 (en) |
CN (1) | CN102482692A (en) |
BR (1) | BRPI1014011A2 (en) |
WO (1) | WO2011002892A2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013192453A1 (en) * | 2012-06-20 | 2013-12-27 | Opx Biotechnologies, Inc. | Purification of 3-hydroxypropionic acid from crude cell broth and dehydration to acrylic acid |
WO2014002886A1 (en) | 2012-06-27 | 2014-01-03 | 株式会社日本触媒 | (meth)acrylic acid production method, and, hydrophilic resin production method |
WO2014145297A1 (en) * | 2013-03-15 | 2014-09-18 | Opx Biotechnologies, Inc. | Method of enhanced bioproduction |
US9512057B2 (en) | 2013-03-15 | 2016-12-06 | Cargill, Incorporated | 3-hydroxypropionic acid compositions |
US10047383B2 (en) | 2013-03-15 | 2018-08-14 | Cargill, Incorporated | Bioproduction of chemicals |
US10337038B2 (en) | 2013-07-19 | 2019-07-02 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
US10465213B2 (en) | 2012-08-10 | 2019-11-05 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
US10494654B2 (en) | 2014-09-02 | 2019-12-03 | Cargill, Incorporated | Production of fatty acids esters |
US11345938B2 (en) | 2017-02-02 | 2022-05-31 | Cargill, Incorporated | Genetically modified cells that produce C6-C10 fatty acid derivatives |
US11408013B2 (en) | 2013-07-19 | 2022-08-09 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
EP4148037A4 (en) * | 2021-01-15 | 2024-02-14 | Lg Chem, Ltd. | Crystals of 3-hydroxypropionate and process of recovering 3-hydroxypropionic acid |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2970085B1 (en) * | 2013-03-15 | 2018-11-07 | Cargill, Incorporated | Recovery of 3-hydroxypropionic acid |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002042418A2 (en) | 2000-11-20 | 2002-05-30 | Cargill, Incorporated | 3-hydroxypropionic acid and other organic compounds |
WO2002090312A1 (en) | 2001-05-07 | 2002-11-14 | Cargill, Incorporated | Process for preparing carboxylic acids and derivatives thereof |
WO2003062173A2 (en) | 2002-01-18 | 2003-07-31 | Cargill, Incorporated | Alanine 2,3- aminomutase |
WO2005003074A1 (en) | 2003-06-26 | 2005-01-13 | Cargill, Incorporated | Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
WO2005021470A2 (en) | 2003-06-26 | 2005-03-10 | Cargill, Incorporated | Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
WO2007042494A2 (en) | 2005-10-10 | 2007-04-19 | Evonik Degussa Gmbh | Microbiological production of 3-hydroxypropionic acid |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02286090A (en) * | 1989-04-18 | 1990-11-26 | Michigan Biotechnol Inst | Preparing and purifying process for lactic acid |
JPH10179183A (en) * | 1996-12-20 | 1998-07-07 | Daicel Chem Ind Ltd | Production of carboxylic acid |
GB0218019D0 (en) * | 2002-08-05 | 2002-09-11 | Ciba Spec Chem Water Treat Ltd | Production of a fermentation product |
US20050272135A1 (en) * | 2004-06-02 | 2005-12-08 | The University Of Chicago | Processs for production and purification of fermentation derived organic acids |
EP1947079B1 (en) * | 2005-10-26 | 2019-05-08 | Mitsui Chemicals, Inc. | Process for producing glycolic acid |
DE102006039203B4 (en) * | 2006-08-22 | 2014-06-18 | Evonik Degussa Gmbh | Process for the preparation of crystallization-purified acrylic acid from hydroxypropionic acid and apparatus therefor |
AU2008206923A1 (en) * | 2007-01-17 | 2008-07-24 | Merck Serono S.A. | Process for the purification of Fc-containing proteins |
CN101294169B (en) * | 2008-04-28 | 2012-01-11 | 河南金丹乳酸科技股份有限公司 | Novel technique for extracting lactic acid with sodium salt fermentation electrodialysis |
US8679304B2 (en) * | 2008-08-26 | 2014-03-25 | Firdose Irani | Apparatus for creating bioactive solution |
-
2010
- 2010-06-30 US US13/379,572 patent/US20120160686A1/en not_active Abandoned
- 2010-06-30 WO PCT/US2010/040613 patent/WO2011002892A2/en active Application Filing
- 2010-06-30 BR BRPI1014011A patent/BRPI1014011A2/en not_active IP Right Cessation
- 2010-06-30 CN CN2010800387921A patent/CN102482692A/en active Pending
- 2010-06-30 EP EP10729773A patent/EP2449122A2/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002042418A2 (en) | 2000-11-20 | 2002-05-30 | Cargill, Incorporated | 3-hydroxypropionic acid and other organic compounds |
US7186541B2 (en) | 2000-11-20 | 2007-03-06 | Cargill, Incorporated | 3-hydroxypropionic acid and other organic compounds |
WO2002090312A1 (en) | 2001-05-07 | 2002-11-14 | Cargill, Incorporated | Process for preparing carboxylic acids and derivatives thereof |
WO2003062173A2 (en) | 2002-01-18 | 2003-07-31 | Cargill, Incorporated | Alanine 2,3- aminomutase |
WO2005003074A1 (en) | 2003-06-26 | 2005-01-13 | Cargill, Incorporated | Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
WO2005021470A2 (en) | 2003-06-26 | 2005-03-10 | Cargill, Incorporated | Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
WO2007042494A2 (en) | 2005-10-10 | 2007-04-19 | Evonik Degussa Gmbh | Microbiological production of 3-hydroxypropionic acid |
Non-Patent Citations (5)
Title |
---|
APPLIED ENVIRONMENTAL MICROBIOLOGY, vol. 59, 1993, pages 4261 - 4265 |
CAUSEY ET AL., PROC. NATL. ACAD. SCI. USA, vol. 101, 2004, pages 2235 - 2240 |
STRAATHOF ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 67, 2005, pages 727 - 734 |
SULLIVAN; CLARKE, J. ASSOC. OFFIC. AGR. CHEMISTS, vol. 38, 1955, pages 514 - 518 |
T. WERPY; G. PETERSEN: "Top Value Added Chemicals from Biomass", PACIFIC NORTHWEST NATIONAL LABORATORY AND NATIONAL RENEWABLE ENERGY LABORATORY, August 2004 (2004-08-01) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013192453A1 (en) * | 2012-06-20 | 2013-12-27 | Opx Biotechnologies, Inc. | Purification of 3-hydroxypropionic acid from crude cell broth and dehydration to acrylic acid |
US9522867B2 (en) | 2012-06-27 | 2016-12-20 | Nippon Shokubai Co., Ltd. | (meth)acrylic acid production method, and, hydrophilic resin production method |
WO2014002886A1 (en) | 2012-06-27 | 2014-01-03 | 株式会社日本触媒 | (meth)acrylic acid production method, and, hydrophilic resin production method |
US10465213B2 (en) | 2012-08-10 | 2019-11-05 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
US10155937B2 (en) | 2013-03-15 | 2018-12-18 | Cargill, Incorporated | Acetyl-CoA carboxylases |
US10047383B2 (en) | 2013-03-15 | 2018-08-14 | Cargill, Incorporated | Bioproduction of chemicals |
US9512057B2 (en) | 2013-03-15 | 2016-12-06 | Cargill, Incorporated | 3-hydroxypropionic acid compositions |
WO2014145297A1 (en) * | 2013-03-15 | 2014-09-18 | Opx Biotechnologies, Inc. | Method of enhanced bioproduction |
US10815473B2 (en) | 2013-03-15 | 2020-10-27 | Cargill, Incorporated | Acetyl-CoA carboxylases |
US10337038B2 (en) | 2013-07-19 | 2019-07-02 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
US11408013B2 (en) | 2013-07-19 | 2022-08-09 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
US10494654B2 (en) | 2014-09-02 | 2019-12-03 | Cargill, Incorporated | Production of fatty acids esters |
US11345938B2 (en) | 2017-02-02 | 2022-05-31 | Cargill, Incorporated | Genetically modified cells that produce C6-C10 fatty acid derivatives |
EP4148037A4 (en) * | 2021-01-15 | 2024-02-14 | Lg Chem, Ltd. | Crystals of 3-hydroxypropionate and process of recovering 3-hydroxypropionic acid |
Also Published As
Publication number | Publication date |
---|---|
US20120160686A1 (en) | 2012-06-28 |
EP2449122A2 (en) | 2012-05-09 |
BRPI1014011A2 (en) | 2015-10-27 |
CN102482692A (en) | 2012-05-30 |
WO2011002892A3 (en) | 2011-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120160686A1 (en) | Process for separating and recovering 3-hydroxypropionic acid | |
Neu et al. | Fermentative utilization of coffee mucilage using Bacillus coagulans and investigation of down-stream processing of fermentation broth for optically pure l (+)-lactic acid production | |
Kumar et al. | Sustainable production and purification of succinic acid: A review of membrane-integrated green approach | |
Xu et al. | In-line and selective phase separation of medium-chain carboxylic acids using membrane electrolysis | |
Madzingaidzo et al. | Process development and optimisation of lactic acid purification using electrodialysis | |
Huang et al. | Application of electrodialysis to the production of organic acids: State-of-the-art and recent developments | |
EP1320410B1 (en) | Bipolar membrane electrodialysis of multivalent metal salts | |
US6712946B2 (en) | Electrodialysis of multivalent metal salts | |
Woźniak et al. | Fumaric acid separation from fermentation broth using nanofiltration (NF) and bipolar electrodialysis (EDBM) | |
Prochaska et al. | Recovery of fumaric acid from fermentation broth using bipolar electrodialysis | |
US7141154B2 (en) | Single-stage separation and esterification of cation salt carboxylates using electrodeionization | |
Khunnonkwao et al. | A two steps membrane process for the recovery of succinic acid from fermentation broth | |
CA2561020A1 (en) | Methods for degrading or converting plant cell wall polysaccharides | |
Lin et al. | Novel resin-based vacuum distillation-crystallisation method for recovery of succinic acid crystals from fermentation broths | |
EP2788493A1 (en) | Method for oxidizing alkanes using an alkb alkane 1-monooxygenase | |
JPH0213386A (en) | Recovery and purification of lactate from full fermentation liquid by electrodialysis | |
Hülber-Beyer et al. | Low-waste fermentation-derived organic acid production by bipolar membrane electrodialysis—An overview | |
Pal et al. | Purification and concentration of gluconic acid from an integrated fermentation and membrane process using response surface optimized conditions | |
WO2017099209A1 (en) | Method for producing 3-oxoadipic acid | |
Urbanus et al. | Integrated product removal of slightly water-soluble carboxylates from fermentation by electrochemically induced crystallization | |
US20120168310A1 (en) | Process for separating and recovering C4 dicarboxylic acids | |
WO2015042114A1 (en) | Fermentation process with distinct growth and production stages | |
US8580096B2 (en) | Bioprocess utilizing carbon dioxide and electrodeionization | |
Stylianou et al. | Development of an electrochemical membrane bioreactor for succinic acid production and in situ separation with engineered Yarrowia lipolytica cultivated on municipal biowaste hydrolysate | |
CN116368232A (en) | Sustainable biomass production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080038792.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10729773 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010729773 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 799/CHENP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13379572 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1014011 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1014011 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111229 |